Clinical significance of atrophy and white matter mean diffusivity within the thalamus of multiple sclerosis patientsRalph H. B. Benedict, Robert Zivadinov, Jeroen J.G. Geurts et al.|Multiple Sclerosis Journal|2013Cited by 104
Thalamic atrophy and dysconnectivity are associated with cognitive impairment in a multi-center, clinical routine, real-word study of people with relapsing-remitting multiple sclerosisRobert Zivadinov, Ralph H. B. Benedict, Andrew L. Smith et al.|NeuroImage Clinical|2024Cited by 13
Lithium’s effects on therapeutic targets and MRI biomarkers in Parkinson’s disease: A pilot clinical trialThomas Guttuso, Niels Bergsland|IBRO Neuroscience Reports|2023Cited by 9
Clinical risk stratification: Development and validation of the DAAE score, a tool for estimating patient risk of transition to secondary progressive multiple sclerosisTom Fuchs, Menno M. Schoonheim, Bernard M.J. Uitdehaag et al.|Multiple Sclerosis and Related Disorders|2024Cited by 5
Quantifying cortical lesions in large legacy multiple sclerosis clinical trial MRI datasets using multi-contrast post-processing and deep learningMichael G. Dwyer, Robert Zivadinov, Jinglan Pei et al.|medRxiv|2025Cited by 3